Personalized Treatment of Glioblastoma: Current State and Future Perspective

Personalized Treatment of Glioblastoma: Current State and Future Perspective

Glioblastoma (GBM) is the most aggressive glial tumor of the central nervous system. Despite intense scientific efforts, patients diagnosed with GBM and treated with the current standard of care have a median survival of only 15 months. Patients are initially treated by a neurosurgeon with the goal...

Full description

Bibliographic Details
Main Authors: Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, Robert Rončević, Tatjana Rotim, Tihana Šimundić, Domagoj Kretić, Marija Perić, Tajana Turk, Damir Štimac
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Biomedicines
Subjects:
glioblastoma
chemotherapy
immunotherapy
neurosurgery
radiotherapy
Online Access:https://www.mdpi.com/2227-9059/11/6/1579

Internet

https://www.mdpi.com/2227-9059/11/6/1579

Similar Items